Coronavirus Update: AstraZeneca Makes Case For Vaxzevria Booster Against Omicron

As CEPI And SK Bio Look At 'Variant-Proof' Vaccines

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.